FFCP PHASE1:Mm9::chr15:101506516..101506534,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=109|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr15:101506516..101506534,-|id=chr15:101506516..101506534,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000996!2.87e-30!1;UBERON:0001723!5.62e-30!1;UBERON:0001033!5.62e-30!1;UBERON:0010056!5.62e-30!1;UBERON:0000161!2.98e-24!5;UBERON:0000078!9.49e-16!2;UBERON:0000165!9.49e-16!2;UBERON:0000166!9.49e-16!2;UBERON:0000930!9.49e-16!2;UBERON:0003102!2.24e-12!23;UBERON:0000162!4.56e-11!3;UBERON:0001353!4.56e-11!3;UBERON:0000163!4.56e-11!3;UBERON:0006866!4.56e-11!3;UBERON:0001046!4.56e-11!3;UBERON:0000164!4.56e-11!3;UBERON:0000931!4.56e-11!3;UBERON:0003975!3.64e-07!5;UBERON:0004122!3.64e-07!5|ontology_enrichment_uberon_v019_2=UBERON:0000996,3.07e-86,1;UBERON:0000162,5.61e-30,3;UBERON:0001353,5.61e-30,3;UBERON:0000163,5.61e-30,3;UBERON:0006866,5.61e-30,3;UBERON:0001046,5.61e-30,3;UBERON:0000164,5.61e-30,3;UBERON:0000931,5.61e-30,3;UBERON:0000161,1.16e-18,5;UBERON:0003975,1.16e-18,5;UBERON:0004122,1.16e-18,5;UBERON:0003134,2.93e-12,8;UBERON:0004175,4.56e-11,9;UBERON:0000474,4.56e-11,9;UBERON:0003100,2.51e-09,11;UBERON:0003064,1.22e-07,14|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.348252166522167,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.680191150845634,0,0,0,0,0,0,10.0753138167161,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr15:101506516..101506534,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=109 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr15:101506516..101506534,- | |||
|description=CAGE_peak_at_chr15:101506516..101506534,- | |||
|id=chr15:101506516..101506534,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000996!2.87e-30!1;UBERON:0001723!5.62e-30!1;UBERON:0001033!5.62e-30!1;UBERON:0010056!5.62e-30!1;UBERON:0000161!2.98e-24!5;UBERON:0000078!9.49e-16!2;UBERON:0000165!9.49e-16!2;UBERON:0000166!9.49e-16!2;UBERON:0000930!9.49e-16!2;UBERON:0003102!2.24e-12!23;UBERON:0000162!4.56e-11!3;UBERON:0001353!4.56e-11!3;UBERON:0000163!4.56e-11!3;UBERON:0006866!4.56e-11!3;UBERON:0001046!4.56e-11!3;UBERON:0000164!4.56e-11!3;UBERON:0000931!4.56e-11!3;UBERON:0003975!3.64e-07!5;UBERON:0004122!3.64e-07!5 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000996,3.07e-86,1;UBERON:0000162,5.61e-30,3;UBERON:0001353,5.61e-30,3;UBERON:0000163,5.61e-30,3;UBERON:0006866,5.61e-30,3;UBERON:0001046,5.61e-30,3;UBERON:0000164,5.61e-30,3;UBERON:0000931,5.61e-30,3;UBERON:0000161,1.16e-18,5;UBERON:0003975,1.16e-18,5;UBERON:0004122,1.16e-18,5;UBERON:0003134,2.93e-12,8;UBERON:0004175,4.56e-11,9;UBERON:0000474,4.56e-11,9;UBERON:0003100,2.51e-09,11;UBERON:0003064,1.22e-07,14 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.348252166522167,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.680191150845634,0,0,0,0,0,0,10.0753138167161,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr15:101506516..101506534,- | |||
}} |
Latest revision as of 00:02, 5 August 2015
Short description: | p@chr15:101506516..101506534, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr15:101506516..101506534, - |
Coexpression cluster: | MCL_coexpression_mm9:109 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
vagina | 3.07e-86 | 1 |
cloaca | 5.61e-30 | 3 |
anal region | 5.61e-30 | 3 |
embryonic cloaca | 5.61e-30 | 3 |
terminal part of digestive tract | 5.61e-30 | 3 |
hindgut | 5.61e-30 | 3 |
primitive urogenital sinus | 5.61e-30 | 3 |
proctodeum | 5.61e-30 | 3 |
orifice | 1.16e-18 | 5 |
internal female genitalia | 1.16e-18 | 5 |
genitourinary system | 1.16e-18 | 5 |
female reproductive organ | 2.93e-12 | 8 |
internal genitalia | 4.56e-11 | 9 |
female reproductive system | 4.56e-11 | 9 |
female organism | 2.51e-09 | 11 |
intermediate mesoderm | 1.22e-07 | 14 |